massarray multiplex pcr method (Sequenom)
90
Structured Review
Sequenom
massarray multiplex pcr method
Massarray Multiplex Pcr Method, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+multiplex+massarray/massarray+multiplex+pcr+method/pmc03599697-133-17-16
Average 90 stars, based on 1 article reviews
Massarray Multiplex Pcr Method, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+multiplex+massarray/massarray+multiplex+pcr+method/pmc03599697-133-17-16
Average 90 stars, based on 1 article reviews
massarray multiplex pcr method - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Multiplex Assay:Article Title: Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes Article Snippet: DNA samples had been centrally assessed for KRAS, NRAS, BRAF and PIK3CA mutations by using a Sequenom MALDI-TOF MassARRAY multiplex PCR method and the Sequenom MassARRAY Assay Design 3·1 software as previously published [ ]. Polymerase Chain Reaction:Article Title: Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes Article Snippet: DNA samples had been centrally assessed for KRAS, NRAS, BRAF and PIK3CA mutations by using a Sequenom MALDI-TOF MassARRAY multiplex PCR method and the Sequenom MassARRAY Assay Design 3·1 software as previously published [ ]. Software:Article Title: Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes Article Snippet: DNA samples had been centrally assessed for KRAS, NRAS, BRAF and PIK3CA mutations by using a Sequenom MALDI-TOF MassARRAY multiplex PCR method and the Sequenom MassARRAY Assay Design 3·1 software as previously published [ ]. |